Placebo-controlled trial of oral laquinimod in multiple sclerosis: MRI evidence of an effect on brain tissue damage

Association between pathological and MRI findings in multiple sclerosis

(2012) Massimo Filippi et al.   LANCET NEUROLOGY

Placebo-Controlled Trial of Oral Laquinimod for Multiple Sclerosis

(2012) Giancarlo Comi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Interferon  -1b and glatiramer acetate effects on permanent black hole evolution

(2011) M. Filippi et al.   NEUROLOGY

Reducing the impact of white matter lesions on automated measures of brain gray and white matter volumes

(2010) Declan T. Chard et al.   JOURNAL OF MAGNETIC RESONANCE IMAGING

Thalamic Damage and Long-term Progression of Disability in Multiple Sclerosis

(2010) Maria Assunta Rocca et al.   RADIOLOGY

Gray matter atrophy in multiple sclerosis: A longitudinal study

(2008) Elizabeth Fisher et al.   ANNALS OF NEUROLOGY

Magnetization transfer ratio evolution with demyelination and remyelination in multiple sclerosis lesions

(2008) Jacqueline T. Chen et al.   ANNALS OF NEUROLOGY

Effect of laquinimod on MRI-monitored disease activity in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study

(2008) G Comi et al.   LANCET

Magnetic resonance imaging metrics and their correlation with clinical outcomes in multiple sclerosis: a review of the literature and future perspectives

(2008) D Bar-Zohar et al.   Multiple Sclerosis Journal